What Is NAD+ Metabolism? A Complete Guide to Pathways, Precursors, and Cellular Energy

NAD+ shows up everywhere: aging research headlines, supplement labels, biochemistry lectures. What gets left out of most of those mentions is a plain explanation of what the molecule actually does inside a cell and how the body keeps its supply running.

NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme that nearly every energy-producing reaction in the cell depends on. Take it away and glycolysis stalls, the citric acid cycle stops turning, and the electron transport chain has nothing left to carry electrons with. Understanding NAD+ metabolism means understanding three things at once: how cells build it, how they spend it, and how they get it back.

This guide covers NAD+ metabolism from the ground up — what the molecule is, the three biosynthesis pathways that produce it, the precursors involved, its role in cellular energy production, and the enzymes that break it down as part of cell signaling. Along the way, it addresses some of the confusion that tends to surround this topic, particularly around precursor supplements.

What Is NAD+?

NAD+ is a coenzyme present in every living cell, made of a nicotinamide group and an adenine nucleotide joined by a diphosphate bridge. Its main job is acting as an electron carrier: NAD+ picks up electrons and becomes NADH, and NADH later hands those electrons off in the electron transport chain to help generate ATP, the cell's main energy currency.

NAD+ does more than carry electrons, though. Several enzyme families use it as a substrate — meaning they consume it outright rather than simply passing it along. That's the reason a cell can't rely on a fixed, one-time supply of NAD+ and instead has to keep resynthesizing it.

NAD+ vs. NADH: What's the Difference?

NAD+ is the oxidized form of the molecule; NADH is the reduced form, carrying a pair of electrons and a hydrogen. Cells shuttle constantly between these two states — NAD+ gets reduced to NADH during glycolysis and the citric acid cycle, then NADH gets oxidized back to NAD+ in the electron transport chain. Researchers often use the ratio of NAD+ to NADH in a cell as a quick read on its metabolic and redox state.

The Three NAD+ Biosynthesis Pathways

Cells don't rely on a single method to make NAD+. Three separate pathways converge on the same end product, each one starting from a different precursor.

The De Novo Pathway (From Tryptophan)

This pathway builds NAD+ starting from the amino acid tryptophan, through a multi-step route called the kynurenine pathway. It's the most metabolically costly of the three, requiring several enzymatic conversions, and in most tissues it contributes a smaller share of the total NAD+ pool than the salvage pathway does.

The Preiss-Handler Pathway (From Nicotinic Acid)

This pathway converts nicotinic acid — also known as niacin, one form of vitamin B3 — into NAD+ through a series of enzymatic steps. It was among the first NAD+ synthesis routes ever identified, and it remains an important dietary contribution pathway.

The Salvage Pathway (From Nicotinamide, NR, and NMN)

The salvage pathway is the dominant route for maintaining NAD+ levels in most human cells. It recycles nicotinamide — a byproduct released when NAD+-consuming enzymes break the molecule down — back into NAD+, and it can also start from nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN), both of which feed into this same recycling loop.

Understanding NAD+ Precursors

A precursor is any molecule the body can convert into NAD+ through one of the three pathways above. The precursors that come up most often, in both scientific literature and consumer conversation, include:

• Nicotinamide (NAM) — the direct substrate of the salvage pathway.
• Nicotinic acid (niacin, vitamin B3) — feeds the Preiss-Handler pathway.
• Nicotinamide riboside (NR) — converted to NMN and then to NAD+ via the salvage pathway.
• Nicotinamide mononucleotide (NMN) — a direct intermediate in the salvage pathway, one step before NAD+.
• Tryptophan — an amino acid that feeds the de novo pathway.

Each of these enters the NAD+ synthesis network at a different point, which is exactly why research comparing them focuses on pathway efficiency and tissue-specific uptake rather than treating them as interchangeable. A precursor two steps from NAD+ and a precursor five steps away are not the same proposition, even if both eventually raise the same coenzyme pool.

NAD+'s Role in Cellular Energy Production

NAD+ is essential to three connected stages of cellular energy metabolism:

Glycolysis

During glycolysis, glucose is broken down in the cytoplasm, and NAD+ is reduced to NADH at a key oxidation step. That NADH has to be reoxidized back to NAD+ for glycolysis to keep running — without a fresh supply of NAD+, the pathway grinds to a halt regardless of how much glucose is available.

The Citric Acid Cycle

In the mitochondrial matrix, the citric acid cycle — also called the Krebs cycle — generates NADH at multiple steps, feeding electrons forward into the next stage of energy production.

The Electron Transport Chain

NADH delivers its electrons to Complex I of the electron transport chain, where they help drive the proton gradient used to generate ATP through oxidative phosphorylation. NAD+ is regenerated in the process and cycles back to glycolysis and the citric acid cycle to be used again.

NAD+ as a Signaling Molecule: The Consumer Enzymes

Outside of energy metabolism, NAD+ is directly consumed — not just recycled — by several enzyme families that use it as a substrate rather than an electron carrier. This consumption is the main reason NAD+ levels have to be continuously replenished rather than simply maintained.

Sirtuins

Sirtuins are a family of NAD+-dependent deacetylase enzymes involved in regulating gene expression, DNA repair, and cellular stress responses. Because they require NAD+ to function at all, sirtuin activity is directly tied to how much NAD+ a cell has on hand.

PARPs (Poly-ADP-Ribose Polymerases)

PARP enzymes use NAD+ as a substrate to carry out DNA damage repair. High levels of DNA damage can drive significant PARP-related NAD+ consumption, which is one reason researchers study PARP activity in the context of cellular stress.

CD38

CD38 is an enzyme that also consumes NAD+, in this case as part of calcium signaling pathways. Its activity tends to increase with certain physiological changes, which is why CD38 comes up frequently in research on NAD+ decline.

Common Mistakes and Misconceptions About NAD+

• Treating NAD+ and NADH as the same molecule rather than two interconvertible redox states.
• Assuming all NAD+ precursors (NR, NMN, niacin) are metabolically identical, when each enters the pathway network at a different point.
• Overlooking that NAD+ plays two very different biochemical roles — a coenzyme that gets recycled, and a substrate that gets consumed.
• Citing preclinical or animal research findings as if they were confirmed human clinical outcomes.
• Ignoring the de novo and Preiss-Handler pathways entirely, since the salvage pathway gets most of the attention.

How to Evaluate NAD+ Research Claims

Step 1: Identify Which Pathway Is Being Discussed

Confirm whether a source is talking about the de novo, Preiss-Handler, or salvage pathway. Findings often apply to one specific route rather than to NAD+ metabolism as a whole, and conflating them is a common source of overstated claims.

Step 2: Check the Study Type

Determine whether the underlying research is an in vitro study, an animal model, or a human clinical trial. These carry very different levels of evidence, and headlines rarely make the distinction clear.

Step 3: Distinguish Precursor from End Product

Recognize that supplementing a precursor, such as NR or NMN, is not the same as directly measuring NAD+ levels. Conversion efficiency varies by tissue and individual, and it remains an active area of ongoing research.

Step 4: Separate Mechanism from Outcome

A study showing that NAD+ activates a sirtuin enzyme in a lab setting is a mechanism finding — it is not proof of any specific real-world health outcome. Mechanism and outcome are different tiers of evidence, and good reporting keeps them apart.

Can You Take NAD+ Itself as a Supplement?

Not directly, in any meaningful way. NAD+ is a large, charged molecule, and taken orally it's broken down during digestion before it can reach cells intact. That's why supplementation in this space is built around precursors — nicotinamide riboside, nicotinamide mononucleotide, or niacin — rather than the coenzyme itself. Each of these smaller, more stable molecules can be absorbed and then converted into NAD+ through the pathways described above, which is also why comparisons between precursors focus so heavily on absorption and conversion efficiency rather than on NAD+ content alone.

Key Takeaways

• NAD+ metabolism refers to the full network of pathways that synthesize, recycle, and consume nicotinamide adenine dinucleotide.
• Three biosynthesis pathways produce NAD+: de novo (from tryptophan), Preiss-Handler (from nicotinic acid), and salvage (from nicotinamide, NR, and NMN) — with the salvage pathway dominant in most tissues.
• NAD+ and NADH represent the oxidized and reduced states of the same molecule, cycling continuously through glycolysis, the citric acid cycle, and the electron transport chain.
• NAD+ is also directly consumed as a substrate by sirtuins, PARPs, and CD38, which is why cells must continuously replenish their NAD+ pool.
• When evaluating NAD+ research or precursor claims, check which pathway, study type, and evidence level is actually being discussed.